- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis | ||
| Mi | Sanofi hops on the US investment bandwagon with $20B commitment through 2030 | ||
| Mi | Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film | ||
| Mi | Roche to reconsider US investment projects if Trump follows through on pricing order | ||
| Mi | Apellis' weak quarter for Syfovre signals uphill climb for geographic atrophy med: analyst | ||
| Mi | AbbVie plant workers in Ireland threaten to strike over pay dispute: reports | ||
| Mi | Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67% | ||
| Mi | CDMO Famar expands reach in Europe with acquisition of sterile manufacturing plant in Germany | ||
| Di | Organon taps into 'romantasy' craze with new Nexplanon ad | ||
| Di | As Bayer's restructuring rolls on, Kerendia and Nubeqa power pharma unit to surprising sales increase | ||
| Di | Roche spotlights Perjeta's staying power with 10-year breast cancer survival results | ||
| Di | Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah | ||
| Di | Mayne hit by misleading drug safety claims from the FDA ahead of $430M buyout | ||
| Di | Bluebird bio warns of potential bankruptcy after another buyout delay | ||
| Di | Novo heads to regulators after Sogroya matches predecessor Norditropin in 3 pediatric growth disorders | ||
| Mo | Madrigal touts biomarker data in key MASH population as it works to grow Rezdiffra's reach | ||
| Mo | Medtronic activates Star power, tapping TV personality to get women discussing heart health | ||
| Mo | Trump signs sweeping executive order to cut US drug prices by 'up to 90%' | ||
| Mo | Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer | ||
| Mo | Roche gets to work on US investment plan with reveal of $700M obesity drug plant in North Carolina | ||
| Mo | AbbVie remains king in doctors' perception of immunology drugmakers, but J&J regains some ground | ||
| Mo | FDA, CDC call for pause of chikungunya shot rollout in older adults | ||
| Mo | Abeona nets $155M with FDA voucher sale just 2 weeks after gene therapy approval | ||
| Fr | Verastem scores FDA nod for first-of-its-kind oral combination to treat rare form of ovarian cancer | ||
| Fr | AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer patients |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .